Gut microbiota and its metabolic products in acute respiratory distress syndrome

The prevalence rate of acute respiratory distress syndrome (ARDS) is estimated at approximately 10% in critically ill patients worldwide, with the mortality rate ranging from 17% to 39%. Currently, ARDS mortality is usually higher in patients with COVID-19, giving another challenge for ARDS treatmen...

Full description

Bibliographic Details

Published in:	Frontiers in Immunology
Main Authors:	Dong-Wei Zhang, Jia-Li Lu, Bi-Ying Dong, Meng-Ying Fang, Xia Xiong, Xue-Jun Qin, Xian-Ming Fan
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-02-01
Subjects:	acute respiratory distress syndrome (ARDS) gut microbiota metabolic products gut-lung axis
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2024.1330021/full